awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35076198-6476945C-F89B-40C1-99B3-C962054E1AE8
Q35076198-6476945C-F89B-40C1-99B3-C962054E1AE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35076198-6476945C-F89B-40C1-99B3-C962054E1AE8
Angiogenesis inhibitors in the treatment of non-small cell lung cancer
P2860
Q35076198-6476945C-F89B-40C1-99B3-C962054E1AE8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35076198-6476945C-F89B-40C1-99B3-C962054E1AE8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
35dcaba7bd5115f07768ffff3a83770c79a7f4fb
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.